Global Cancer Immunotherapy Market Size study, By Type, By Application, By End User, and Regional Forecasts 2022-2028

List of Tables

Global Cancer Immunotherapy Market is valued approximately USD 119.31 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.0% over the forecast period 2022-2028.

Cancer immunotherapy is a procedure for the stimulation of the immune system to cure cancer and boosts the natural ability to fight against the disease. This therapy is gaining huge traction among the population as it offers long-term cancer protection, has fewer side effects, and cures a variety of cancer. Cancer immunotherapy is adopted in a wide range of cancers such as prostate cancer, lung cancer, colorectal cancer, melanoma, head & neck cancer, breast cancer, and many others. The growing incidences of cancer, increasing development of bioinformatics tools to enhance the drug development process, coupled with the rising adoption of immunotherapy compared to other treatment options are the primary factors that are fostering market growth around the world. For instance, according to the national cancer institute, there were nearly 18.1 million new cases and 9.5 million cancer-associated deaths occurred across the globe in 2018. Moreover, the amount is likely to reach 29.5 million and the number of cancer-associated deaths to 16.4 million by the end of 2040. Thus, the growing occurrence of cancer globally is anticipated to surge the demand for cancer immunotherapy, which, in turn, accelerates the market growth in the near future. However, the availability of limited funds to initiate clinical trials and the high cost of treatment impede the growth of the market over the forecast period of 2022-2028. Also, increasing clinical trials for the treatment of cancers and high growth prospects in emerging nations are anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the Global Cancer Immunotherapy Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the rising adoption rate of immunotherapy and increasing investment for the drug development process. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing presence of the target population, and growth of the emerging economies such as India and China would create lucrative growth prospects for the Cancer Immunotherapy market across the Asia-Pacific region.

Major market players included in this report are:

Amgen, Inc.

Astrazeneca, PLC

F. Hoffmann-La Roche, Ltd. (Genentech, Inc.)

Bayer AG

Eli Lily And Company

Novartis AG

Pfizer, Inc.

Johnson & Johnson (Janssen Global Services, LLC)

Bristol-Myers Squibb Company

Merck KGAA

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type

Monoclonal Antibodies

Cancer Vaccines

Checkpoint Inhibitors

Immunomodulators

By Application

Lung Cancer

Breast Cancer

Head and Neck Cancer

Prostate Cancer

Colorectal Cancer

Melanoma

Others

By End User

Hospitals

Clinics & Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Cancer Immunotherapy Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Global Cancer Immunotherapy Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Global Cancer Immunotherapy Market, by Type, 2020-2028 (USD Billion)
- 1.2.3. Global Cancer Immunotherapy Market, by Application, 2020-2028 (USD Billion)
- 1.2.4. Global Cancer Immunotherapy Market, by End User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Cancer Immunotherapy Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Cancer Immunotherapy Market Dynamics

3.1. Cancer Immunotherapy Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
  - 3.1.1.1. Growing incidence of cancer worldwide
  - 3.1.1.2. Rising adoption of immunotherapy over other treatment options
- 3.1.2. Market Challenges
  - 3.1.2.1. Availability of limited funds to initiate clinical trials
  - 3.1.2.2. High cost of treatment
- 3.1.3. Market Opportunities
  - 3.1.3.1. Increasing clinical trials for the treatment of cancers
  - 3.1.3.2. High growth prospects in emerging nations

Chapter 4. Global Cancer Immunotherapy Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Cancer Immunotherapy Market, by Type

6.1. Market Snapshot
6.2. Global Cancer Immunotherapy Market by Type, Performance - Potential Analysis
6.3. Global Cancer Immunotherapy Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
6.4. Cancer Immunotherapy Market, Sub Segment Analysis
- 6.4.1. Monoclonal Antibodies
- 6.4.2. Cancer Vaccines
- 6.4.3. Checkpoint Inhibitors
- 6.4.4. Immunomodulators

Chapter 7. Global Cancer Immunotherapy Market, by Application

7.1. Market Snapshot
7.2. Global Cancer Immunotherapy Market by Application, Performance - Potential Analysis
7.3. Global Cancer Immunotherapy Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
7.4. Cancer Immunotherapy Market, Sub Segment Analysis
- 7.4.1. Lung Cancer
- 7.4.2. Breast Cancer
- 7.4.3. Head and Neck Cancer
- 7.4.4. Prostate Cancer
- 7.4.5. Colorectal Cancer
- 7.4.6. Melanoma
- 7.4.7. Others

Chapter 8. Global Cancer Immunotherapy Market, by End User

8.1. Market Snapshot
8.2. Global Cancer Immunotherapy Market by End User, Performance - Potential Analysis
8.3. Global Cancer Immunotherapy Market Estimates & Forecasts by End User 2018-2028 (USD Billion)
8.4. Cancer Immunotherapy Market, Sub Segment Analysis
- 8.4.1. Hospitals
- 8.4.2. Clinics & Others

Chapter 9. Global Cancer Immunotherapy Market, Regional Analysis

9.1. Cancer Immunotherapy Market, Regional Market Snapshot
9.2. North America Cancer Immunotherapy Market
- 9.2.1. U.S. Cancer Immunotherapy Market
  - 9.2.1.1. Type estimates & forecasts, 2018-2028
  - 9.2.1.2. Application estimates & forecasts, 2018-2028
  - 9.2.1.3. End User estimates & forecasts, 2018-2028
- 9.2.2. Canada Cancer Immunotherapy Market
9.3. Europe Cancer Immunotherapy Market Snapshot
- 9.3.1. U.K. Cancer Immunotherapy Market
- 9.3.2. Germany Cancer Immunotherapy Market
- 9.3.3. France Cancer Immunotherapy Market
- 9.3.4. Spain Cancer Immunotherapy Market
- 9.3.5. Italy Cancer Immunotherapy Market
- 9.3.6. Rest of Europe Cancer Immunotherapy Market
9.4. Asia-Pacific Cancer Immunotherapy Market Snapshot
- 9.4.1. China Cancer Immunotherapy Market
- 9.4.2. India Cancer Immunotherapy Market
- 9.4.3. Japan Cancer Immunotherapy Market
- 9.4.4. Australia Cancer Immunotherapy Market
- 9.4.5. South Korea Cancer Immunotherapy Market
- 9.4.6. Rest of Asia Pacific Cancer Immunotherapy Market
9.5. Latin America Cancer Immunotherapy Market Snapshot
- 9.5.1. Brazil Cancer Immunotherapy Market
- 9.5.2. Mexico Cancer Immunotherapy Market
9.6. Rest of The World Cancer Immunotherapy Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies
10.2. Company Profiles
- 10.2.1. Amgen, Inc.
  - 10.2.1.1. Key Information
  - 10.2.1.2. Overview
  - 10.2.1.3. Financial (Subject to Data Availability)
  - 10.2.1.4. Product Summary
  - 10.2.1.5. Recent Developments
- 10.2.2. Astrazeneca, PLC
- 10.2.3. F. Hoffmann-La Roche, Ltd. (Genentech, Inc.)
- 10.2.4. Bayer AG
- 10.2.5. Eli Lily And Company
- 10.2.6. Novartis AG
- 10.2.7. Pfizer, Inc.
- 10.2.8. Johnson & Johnson (Janssen Global Services, LLC)
- 10.2.9. Bristol-Myers Squibb Company
- 10.2.10. Merck KGAA

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Cancer Immunotherapy Market, report scope
TABLE 2. Global Cancer Immunotherapy Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Cancer Immunotherapy Market estimates & forecasts by Type 2018-2028 (USD Billion)
TABLE 4. Global Cancer Immunotherapy Market estimates & forecasts by Application 2018-2028 (USD Billion)
TABLE 5. Global Cancer Immunotherapy Market estimates & forecasts by End User 2018-2028 (USD Billion)
TABLE 6. Global Cancer Immunotherapy Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Cancer Immunotherapy Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Cancer Immunotherapy Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Cancer Immunotherapy Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Cancer Immunotherapy Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Cancer Immunotherapy Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Cancer Immunotherapy Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Cancer Immunotherapy Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Cancer Immunotherapy Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Cancer Immunotherapy Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. U.S. Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 20. Canada Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 23. UK Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 26. Germany Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 29. RoE Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 32. China Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 35. India Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 38. Japan Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 41. RoAPAC Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 44. Brazil Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 47. Mexico Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 50. RoLA Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row Cancer Immunotherapy Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 53. Row Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Cancer Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Cancer Immunotherapy Market
TABLE 56. List of primary sources, used in the study of global Cancer Immunotherapy Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

FIG 1. Global Cancer Immunotherapy Market, research methodology
FIG 2. Global Cancer Immunotherapy Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Cancer Immunotherapy Market, key trends 2021
FIG 5. Global Cancer Immunotherapy Market, growth prospects 2022-2028
FIG 6. Global Cancer Immunotherapy Market, porters 5 force model
FIG 7. Global Cancer Immunotherapy Market, pest analysis
FIG 8. Global Cancer Immunotherapy Market, value chain analysis
FIG 9. Global Cancer Immunotherapy Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Cancer Immunotherapy Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Cancer Immunotherapy Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Cancer Immunotherapy Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Cancer Immunotherapy Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Cancer Immunotherapy Market, regional snapshot 2018 & 2028
FIG 15. North America Cancer Immunotherapy Market 2018 & 2028 (USD Billion)
FIG 16. Europe Cancer Immunotherapy Market 2018 & 2028 (USD Billion)
FIG 17. Asia pacific Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Cancer Immunotherapy Market 2018 & 2028 (USD Billion)
FIG 19. Global Cancer Immunotherapy Market, company Market share analysis (2021)